Adial Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.54 | -$0.54 | -$0.54 |
| Q2 2024 | 2 | -$0.44 | -$0.44 | -$0.44 |
| Q3 2024 | 1 | -$0.40 | -$0.40 | -$0.40 |
| Q1 2025 | 1 | -$0.40 | -$0.40 | -$0.40 |
| Q2 2025 | 1 | -$0.37 | -$0.37 | -$0.37 |
| Q3 2025 | 1 | -$0.37 | -$0.37 | -$0.37 |
| Q4 2025 | 1 | -$0.37 | -$0.37 | -$0.37 |
Adial Pharmaceuticals, Inc. Earnings Date And Information
Adial Pharmaceuticals, Inc. last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-0.59 earnings per share for the quarter, missing analysts' consensus estimates of $-0.39 by $0.2. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Adial Pharmaceuticals, Inc. has generated $-5 earnings per share over the last year ($-4.91 diluted earnings per share) and currently has a price-to-earnings ratio of -0.35. Adial Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.
Adial Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2024 | Q2 2024 | -$0.39 | -$0.59 | -0.2 | $0 | $0 |
| 05/14/2024 | Q1 2024 | -$0.51 | -$2.19 | -1.68 | $0 | |
| 04/01/2024 | Q4 2023 | -$1.15 | $32,246 | |||
| 09/29/2023 | Q3 2023 | -$1.18 | $0 | |||
| 08/21/2023 | Q2 2023 | -$1.50 | -$1.39 | 0.11 | $0 | |
| 05/12/2023 | Q1 2023 | -$3.50 | -$2.73 | 0.77 | $0 | |
| 03/30/2023 | Q4 2022 | -$3.75 | -$2.69 | 1.06 | $0 | |
| 11/14/2022 | Q3 2022 | -$4.50 | -$2.95 | 1.55 | $0 | |
| 08/12/2022 | Q2 2022 | -$3.97 | $0 | |||
| 05/13/2022 | Q1 2022 | -$4.25 | -$2.98 | 1.27 | $0 | |
| 03/28/2022 | Q4 2021 | -$0.21 | -$7.10 | -6.89 | $0 | |
| 11/12/2021 | Q3 2021 | -$5.50 | -$5.44 | 0.06 | $0 | |
| 08/12/2021 | Q2 2021 | -$0.20 | -$6.31 | -6.11 | $0 | |
| 05/17/2021 | Q1 2021 | -$7.59 | $0 | |||
| 03/22/2021 | Q4 2020 | -$0.25 | -$6.03 | -5.78 | $0 | |
| 11/13/2020 | Q3 2020 | -$0.18 | -$6.11 | -5.93 | $0 | |
| 08/13/2020 | Q2 2020 | -$0.18 | -$4.01 | -3.83 | $0 | |
| 05/14/2020 | Q1 2020 | -$5.42 | $0 | |||
| 03/20/2020 | Q4 2019 | -$4.85 | $0 | |||
| 11/14/2019 | Q3 2019 | -$4.18 | $0 |
Adial Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Adial Pharmaceuticals, Inc.'s earnings date?
Adial Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
-
How can I listen to Adial Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Adial Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Adial Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Adial Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does Adial Pharmaceuticals, Inc. generate each year?
Adial Pharmaceuticals, Inc. (:ADIL) has a recorded net income of $0. Adial Pharmaceuticals, Inc. has generated $-4.92 earnings per share over the last four quarters.
-
What is Adial Pharmaceuticals, Inc.'s price-to-earnings ratio?
Adial Pharmaceuticals, Inc. (:ADIL) has a price-to-earnings ratio of -0.35 and price/earnings-to-growth ratio is -0.03.
